NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

The present invention relates to a compound of the formula (i) wherein Ar represents a phenyl or a 6-membered heteroaryl group, R1 and R2 represent independently a hydrogen atom or a deuterium atom, R3 represents (1) a -COR4 group, (2) a -BOR5OR6 group, (3) a -X-Z group, (4) a (C1-C6)alkyl group or...

Full description

Saved in:
Bibliographic Details
Main Authors BOISNARD, Sabine, TABART, Michel, NICOLAI, Eric, EL-AHMAD, Youssef, VIVET, Bertrand, FETT, Eykmar, TERRIER, Corinne, HALLEY, Frank
Format Patent
LanguageEnglish
French
German
Published 11.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a compound of the formula (i) wherein Ar represents a phenyl or a 6-membered heteroaryl group, R1 and R2 represent independently a hydrogen atom or a deuterium atom, R3 represents (1) a -COR4 group, (2) a -BOR5OR6 group, (3) a -X-Z group, (4) a (C1-C6)alkyl group or a (C1-C6)alkenyl group, (5) a -X-S(O)n(R7)p(R8)q group, (6) a halogen atom, a -NH2 group or a -CN group, (7) a -O-R11 group, (8) a -NH-COR9 group, (9) a -C(═NH)NHOH group, (10) a -NH-C(NH)-R9′ group, or (11) a -NHCOCOOR12 group or a -NHCOCONR12′R12″ group, X represents abond, a -NH- group, a -CONH- group or a -CO- group, Z represents a 4 or 5-membered cycloalkyl, a 4 or 5-membered heterocylcloalkyl group, a 4 or 5-membered heteroaryl group or a phenyl group or a pharmaceutically acceptable salt thereof. The present invention further relates to a medicament comprising said compound of formula (I) and to said compound of formula (I) for use as an inhibitor and degrader of estrogen receptors.
Bibliography:Application Number: EP20200789490